Brain gut axis-new view

Current Neuropharmacology

Volumn 14, Issue 8, 2016, Pages 840-841

  Sikiric, Predrag ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ENDOCANNABINOID; GHRELIN; GLUCAGON LIKE PEPTIDE 1; HYDROGEN SULFIDE; LEPTIN; MELATONIN; NEUROTRANSMITTER; NUCLEOBINDIN;

BRAIN-GUT AXIS; CARCINOGENESIS; COGNITION; EDITORIAL; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE MOTILITY; INTESTINE MUCOSA; MAJOR DEPRESSION; MESENCHYMAL STEM CELL; NERVOUS SYSTEM INFLAMMATION; NEUROTRANSMISSION; PYLOROPLASTY; STOMACH CANCER; VAGOTOMY; ANIMAL; BRAIN; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; GASTROINTESTINAL TRACT; HUMANS;

EID: 85015996829     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X1408161031125729     Document Type: Editorial

References (12)

1. Brzozowski, B., Mazur-Bialy, A., Pajdo, R., Kwiecien, S., Bilski, J., Zwolinska-Wcislo, M., Mach, T., Brzozowski, T. Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD). Role of Brain-Gut Axis. Curr. Neuropharmacol., 2016, 14, 892-900.
2. Goebel-Stengel, M., Stengel, A. Role of brain NUCB2/nesfatin-1 in the stress-induced modulation of gastrointestinal functions. Curr. Neuropharmacol., 2016, 14, 882-891.
3. Sgambato, D., Capuano, A., Sullo, M.G., Miranda, A., Federico, A., Romano, M. Gut-Brain Axis in Gastric Mucosal Damage and Protection. Curr. Neuropharmacol., 2016, 14, 959-966.
4. Gyires, K., Zádori, Z.S. Role of cannabinoids in gastrointestinal mucosal defense and inflammation. Curr. Neuropharmacol., 2016,14, 935-951.
5. Filaretova, L., Myazina, M., Bagaeva, T. The realization of the brain gut interactions with corticotropin-releasing factor and glucocorticoids. Curr. Neuropharmacol., 2016, 14, 876-881.
6. Abe, N., Kumano, A., Takeuchi, K. Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Enteropathy in Rats. Curr. Neuropharmacol., 2016, 14, 866-875.
7. Szabo, I.L., Czimmer, J., Mozsik, G. Cellular Energetical Actions of “Chemical” and “Surgical” Vagotomy in Gastrointestinal Mucosal Damage and Protection: Similarities, Differences and Significance for Brain-Gut Function. Curr. Neuropharmacol., 2016, 14, 901-913.
8. Rabben, H.L., Zhao, C-M., Hayakawa, Y., Wang, T.C., Chen, D. Vagotomy and Gastric Tumorigenesis. Curr. Neuropharmacol., 2016, 14, 967-972.
9. Tsang, S.W., Auyeung, K.K.W., Bian, Z.X., Ko, J.K.S. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis. Curr. Neuropharmacol., 2016, 14, 842-856.
10. Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Batelja, L., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic, D., Madzarac, G., Rukavina I., Sucic, M., Baric, M., Starcevic, N., Krstonijevic, Z., Lovric, B. M. Brain-gut axis and stable gastric pentadecapeptide BPC 157. Theoretical and practical implications. Curr. Neuropharmacol., 2016, 14, 857-865.
11. Földes, A., Kádár, K., Kerémi, B., Gyires, K., Zádori, Z.S., Varga, G. Mesenchymal stem cells of dental origin-their potential for anti-inflammatory and regenerative actions in brain and gut damage. Curr. Neuropharmacol., 2016, 14, 914-934.
12. Vlainić, J., Šuran, J., Vlainić, T., Vukorep, A.L. Brain-gut axis: Probiotics as an adjuvant therapy in major depressive disorder. Curr. Neuropharmacol., 2016, 14, 952-958.